SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-005990
Filing Date
2024-05-13
Accepted
2024-05-13 16:56:13
Documents
14
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnpx_8k-051324.htm   iXBRL 8-K 24399
2 PRESS RELEASE ex99-01.htm EX-99.01 115986
  Complete submission text file 0001999371-24-005990.txt   328137

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20240513.xsd EX-101.SCH 2991
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20240513_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20240513_pre.xml EX-101.PRE 22343
17 EXTRACTED XBRL INSTANCE DOCUMENT tnpx_8k-051324_htm.xml XML 3549
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24939971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)